Navid Ajabshir
Papers
1
Total Citations
2
H-Index
1
About
Navid Ajabshir is a surgical oncologist whose research focuses on intraoperative molecular imaging (IMI) and precision-guided cancer surgery. His major contribution lies in advancing the clinical translation of folate receptor-targeted fluorescent agents, particularly pafolacianine, for real-time tumor localization during lung cancer resections. In his landmark 2025 study, Ajabshir demonstrated the integration of this FDA-approved agent into routine surgical workflows, enabling surgeons to identify occult nodules and achieve more complete sublobar resections—a critical advancement for preserving lung function. This work, already garnering early citations, addresses a long-standing challenge in thoracic oncology: the inability to visualize microscopic disease intraoperatively. By validating a commercially available IMI platform, Ajabshir has helped bridge the gap between molecular imaging research and everyday clinical practice. His findings suggest that targeted fluorescence can reduce positive margin rates and improve oncologic outcomes without extending operative time. For students and researchers, Ajabshir’s work exemplifies how bench-to-bedside innovation in optical imaging is reshaping the standard of care for lung cancer surgery, offering a tangible path toward more precise, patient-centered resections.
Research Focus
Key Achievements
Top Papers
- 1